DAM
DLD Asset Management Portfolio holdings
AUM
$844M
This Quarter Return
+1.59%
1 Year Return
+2.69%
3 Year Return
+14.51%
5 Year Return
+47.59%
10 Year Return
–
AUM
$684M
AUM Growth
+$684M
(+3.4%)
Cap. Flow
+$87.9M
Cap. Flow
% of AUM
12.86%
Top 10 Holdings %
Top 10 Hldgs %
59.35%
Holding
131
New
36
Increased
9
Reduced
1
Closed
28
Top Buys
| 1 |
NXP Semiconductors
NXPI
|
$19.1M |
| 2 |
LCI
Lannett Company, Inc.
LCI
|
$14.8M |
| 3 |
MON
Monsanto Co
MON
|
$14.2M |
| 4 |
PF
Pinnacle Foods, Inc.
PF
|
$13.9M |
| 5 |
VR
Validus Hold Ltd
VR
|
$10.7M |
Top Sells
| 1 |
Cognizant
CTSH
|
$51.6M |
| 2 |
KSU
Kansas City Southern
KSU
|
$31.5M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$4.46M |
| 4 |
Pacira BioSciences
PCRX
|
$3.95M |
| 5 |
OTIC
Otonomy, Inc.
OTIC
|
$2.83M |
Sector Composition
| 1 | Technology | 7.21% |
| 2 | Consumer Staples | 6.55% |
| 3 | Financials | 4.1% |
| 4 | Materials | 3.25% |
| 5 | Healthcare | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
AT&T
T
$208B
| – | – |
0
| – | – |
|
102
Trip.com Group
TCOM
$46.6B
| – | – |
0
| – | – |
|
103
Teva Pharmaceuticals
TEVA
$21.5B
| – | – |
0
| – | – |
|
|
ITCI
104
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
0
| – | – |
|
|
NTBL
105
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| – | – |
0
| – | – |
|
|
VGR
106
DELISTED
Vector Group Ltd.
VGR
| – | – |
0
| – | – |
|
|
RAD
107
DELISTED
Rite Aid Corporation
RAD
| – | – |
-15,400
| Closed | -$30K |
|
|
ACOR
108
DELISTED
Acorda Therapeutics, Inc.
ACOR
| – | – |
0
| – | – |
|